









Markets
/
Stocks
/
nasdaq-zbh
/

Zimmer Biomet Holdings Inc

ZBH

99.560USD

-0.150-0.15%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

19.70BMarket Cap

23.93P/E TTM



Zimmer Biomet Holdings Inc

99.560

-0.150-0.15%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Zimmer Biomet Holdings Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Zimmer Biomet Holdings Inc's Score

Industry at a Glance

Industry Ranking

10 / 210

Overall Ranking

54 / 4621

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 30 analysts

Hold

Current Rating

111.922

Target Price

+12.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Zimmer Biomet Holdings Inc Highlights

StrengthsRisks

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 7.68B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 21.51%.

Fairly Valued

The company’s latest PE is 24.19, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 195.80M shares, decreasing 0.39% quarter-over-quarter.

Held by Robert Olstein

Star Investor Robert Olstein holds 78.00K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 9.30, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 2.08B, representing a year-over-year increase of 6.97%, while its net profit experienced a year-over-year increase of 37.07%.

Score

Industry at a Glance

Previous score

9.30

Change



Financials

6.76

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.77

Key Metrics

Free cash flow

No Data

Zimmer Biomet Holdings Inc's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 7.64, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 24.18, which is 390.40% below the recent high of 118.60 and 20.04% above the recent low of 19.34.

Score

Industry at a Glance

Previous score

7.64

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 10/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 6.93, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Zimmer Biomet Holdings Inc is 110.00, with a high of 140.00 and a low of 96.00.

Score

Industry at a Glance

Previous score

6.93

Change

Support & Resistance

No Data

Analyst Rating

Based on 30 analysts

Hold

Current Rating

111.922

Target Price

+12.25%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Zimmer Biomet Holdings Inc

ZBH

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Insulet Corp

PODD

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 7.23, which is higher than the Healthcare Equipment & Supplies industry's average of 6.55. Sideways: Currently, the stock price is trading between the resistance level at 106.29 and the support level at 93.42, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.25

Change

-0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.017

Buy

RSI(14)

45.877

Neutral

STOCH(KDJ)(9,3,3)

18.594

Sell

ATR(14)

2.220

Low Volatility

CCI(14)

-48.512

Neutral

Williams %R

56.876

Sell

TRIX(12,20)

0.101

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

101.312

Sell

MA10

102.105

Sell

MA20

100.146

Sell

MA50

101.559

Sell

MA100

98.316

Buy

MA200

100.623

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 98.84%, representing a quarter-over-quarter increase of 2.72%. The largest institutional shareholder is The Vanguard, holding a total of 23.16M shares, representing 11.69% of shares outstanding, with 2.10% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

23.16M

+0.86%

Dodge & Cox

Star Investors

22.10M

+10.01%

T. Rowe Price Associates, Inc.

Star Investors

14.50M

+2.37%

BlackRock Institutional Trust Company, N.A.

10.93M

-1.75%

State Street Investment Management (US)

8.75M

-0.08%

Capital International Investors

6.77M

American Century Investment Management, Inc.

5.71M

+8.74%

Geode Capital Management, L.L.C.

5.12M

+1.37%

PRIMECAP Management Company

Star Investors

4.71M

+0.59%

Franklin Mutual Advisers, LLC

4.02M

+18.47%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 8.73, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.